|
|
acute erythroblastic leukemia
acute leukemia of ambiguous lineage + An acute leukemia in which the blasts lack sufficient evidence to classify as myeloid or lymphoid or they have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells. (WHO, 2001)
acute monocytic leukemia +
acute myeloid leukemia by FAB classification +
acute myeloid leukemia with CEBPA somatic mutations
acute myeloid leukemia with multilineage dysplasia
acute myeloid leukemia with mutated NPM1
acute myeloid leukemia, biallelic CEBPA gene mutation
acute myeloid leukemia, CEBPA gene mutation
acute myeloid leukemia, del(13q14-q21)
acute myeloid leukemia, del(5q31-q32)
acute myeloid leukemia, der12p
acute myeloid leukemia, FLT3 internal tandem duplication
acute myeloid leukemia, FLT3 tyrosine kinase domain point mutation
acute myeloid leukemia, GATA1 gene mutation
acute myeloid leukemia, inv(16)(p13.1;q22)
acute myeloid leukemia, inv(16)(p13.3;q24.3)
acute myeloid leukemia, inv(3)(q21.3;q26.2)
acute myeloid leukemia, KIT exon 17 mutation
acute myeloid leukemia, KIT exon 8 mutation
acute myeloid leukemia, KIT gene mutation
acute myeloid leukemia, KRAS gene mutation
acute myeloid leukemia, loss of chromosome 17p
acute myeloid leukemia, MLL gene rearrangement
acute myeloid leukemia, monoallelic CEBPA gene mutation
acute myeloid leukemia, Monosomy 5
acute myeloid leukemia, Monosomy 7
acute myeloid leukemia, Non-KMT2A MLLT10 rearrangement positive
acute myeloid leukemia, NRAS gene mutation
acute myeloid leukemia, PTPN11 gene mutation
acute myeloid leukemia, RUNX1 gene mutation
acute myeloid leukemia, t(10;11)(p11.2;q23)
acute myeloid leukemia, t(10;11)(p12;q23)
acute myeloid leukemia, t(11;15)(p15;q35)
acute myeloid leukemia, t(11;17)
acute myeloid leukemia, t(11;19)(q23.3;p13.3)
acute myeloid leukemia, t(11;19)(q23;p13)
acute myeloid leukemia, t(11;19)(q23;p13.1)
acute myeloid leukemia, t(15;17)(q24;q21)
acute myeloid leukemia, t(16;16)(p13.1;q22)
acute myeloid leukemia, t(16;21)(p11;q22)
acute myeloid leukemia, t(16;21)(q24;q22)
acute myeloid leukemia, t(1;11)(q21;q23)
acute myeloid leukemia, t(1;22)
acute myeloid leukemia, t(2;12)
acute myeloid leukemia, t(3;12)(q23;p12.3)
acute myeloid leukemia, t(3;3)(q21.3;q26.2)
acute myeloid leukemia, t(3;5)(q25;q34)
acute myeloid leukemia, t(4;11)(q21;q23)
acute myeloid leukemia, t(5;11)(q35;p15)
acute myeloid leukemia, t(6;11)(q27;q23)
acute myeloid leukemia, t(6;9)(p23;q34.1)
acute myeloid leukemia, t(7;12)(q36;p13)
acute myeloid leukemia, t(8;16)
acute myeloid leukemia, t(9;11)(p21.3;q23.3)
acute myeloid leukemia, t(9;22)(q34.1;q11.2)
acute myeloid leukemia, t(v;11q23.3)
acute myeloid leukemia, Trisomy 8
acute myeloid leukemia, WT1 gene mutation
acute promyelocytic leukemia
adult acute myeloid leukemia
childhood acute myeloid leukemia
core binding factor acute myeloid leukemia
inherited acute myeloid leukemia +
therapy related acute myeloid leukemia and myelodysplastic syndrome
|
|